Aktis Oncology (AKTS) Q3 2024 Earnings

Oct 8Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-1.14
-0.79
-0.45
-0.1

Details

Expected EPS
-0.1
Actual EPS
-1.14
Surprise EPS
-1.04
Surprise Percent
-1,040%

Description

⁨Aktis Oncology⁩ (⁦AKTS⁩) has reported earnings of ⁦-1.14⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts